EUVIMEDEUVIMED entdecken
Open Access

ASIV Attenuates Cisplatin‐Induced Proximal Tubular Injury by Enhancing Mitochondrial Biogenesis and Mitophagy Through the ADRA1A / AMPK / FOXO3A Pathway

Meng Wang iD, Wang Peng, Yani Wei, Hangxing Yu, Yan Luo, Qin Zhang, Xu Guan, Ying Li, Jianwei Wang, Qiurui Li, Weijian Xiong iD

The FASEB Journal · 15.09.2026 · 40 (17)

DOI: 10.1096/fj.202602118r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 03.09.2026. Verfasst von Meng Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Department, Chongqing Traditional Chinese Medicine Hospital, Chongqing, China. Hauptthemen laut MEDLINE: Cisplatin, Forkhead Box Protein O3, Mitophagy, Kidney Tubules, Proximal. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CSTC | Chongqing Science and Technology Foundation, 2025 World Special Project of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cisplatin causes nephrotoxicity by accumulating in renal tubular epithelial cells (RTECs). Astragaloside IV (ASIV) shows renoprotective potential, but its mechanisms remain poorly understood. Cisplatin induced nephrotoxicity was established in 8‐week‐old male C57BL/6 mice via intraperitoneal administration of cisplatin at 20 mg/kg for 48 h. For in vitro studies, HK‐2 human proximal tubular epithelial cells were exposed to 50 μM cisplatin for 24 h. Multi‐omics approaches were employed to identify novel mechanisms by which ASIV ameliorates cisplatin‐induced proximal tubular injury. ASIV markedly reduced serum creatinine and urea nitrogen levels in mice, and ameliorated cisplatin‐induced proximal tubular injury both in vivo and in vitro. Moreover, ASIV restored mitochondrial damage, upregulated protein expression of PGC‐1α, TOMM20, and PINK1 in RTECs. Mechanistically, RNA‐seq and scRNA‐seq revealed that cisplatin predominantly affected ADRA1A‐mediated mitochondrial biogenesis and mitophagy in proximal tubular cells, accompanied by suppression of the AMPK/FOXO3A pathway. Notably, ASIV upregulated ADRA1A expression, thereby facilitating AMPK and FOXO3A phosphorylation and consequently enhancing mitochondrial biogenesis and mitophagy. Furthermore, dabuzalgron (a selective ADRA1A agonist) recapitulated the protective effects of ASIV. In contrast, the renoprotective action of ASIV against cisplatin‐induced proximal tubular injury was largely abrogated by the ADRA1A antagonist tamsulosin in vivo and by ADRA1A‐specific siRNA in vitro. These findings identify ASIV as a highly promising renoprotective agent that upregulates ADRA1A expression and activates the AMPK/FOXO3A axis to enhance mitochondrial biogenesis and mitophagy, thereby counteracting cisplatin‐induced proximal tubular injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinForkhead Box Protein O3MitophagyKidney Tubules, ProximalSaponinsAMP-Activated Protein KinasesTriterpenesOrganelle BiogenesisAcute Kidney InjuryAnimalsMaleMiceMice, Inbred C57BLHumansMitochondriaSignal TransductionMitochondrial Precursor Protein Import Complex ProteinsEpithelial CellsCell LinePTEN-Induced Putative Kinase

Stichwörter der Autor:innen

Astragaloside IVacute kidney injuryalpha‐1A adrenergic receptor (ADRA1A)cisplatinrenal tubular epithelial cells

Substanzen

CisplatinForkhead Box Protein O3SaponinsFoxO3 protein, mouseAMP-Activated Protein KinasesTriterpenesastragaloside AMitochondrial Precursor Protein Import Complex ProteinsTomm20 protein, mousePTEN-Induced Putative Kinase

Autor:innen und Institutionen

  • Nephrology Department, Chongqing Traditional Chinese Medicine Hospital, Chongqing, China.
  • Chongqing Key Laboratory of Traditional Chinese Medicine for Prevention and Cure of Metabolic Diseases, College of Traditional Chinese Medicine, Chongqing Medical University, Chongqing, China.
  • Chongqing Key Laboratory of Traditional Chinese Medicine for Prevention and Cure of Metabolic Diseases, Key Laboratory of Anti-Inflammatory and Immunological Traditional Chinese Medicine Research and Development, Colleg…
  • Breast Department, Chongqing Traditional Chinese Medicine Hospital, Chongqing, China.

ORCID-Profile: Meng Wang, Weijian Xiong

Förderung

  • CSTC | Chongqing Science and Technology Foundation
  • 2025 World Special Project of Traditional Chinese Medicine

Zitieren

APA

Wang, M., Peng, W., Wei, Y., Yu, H., Luo, Y., Zhang, Q., Guan, X., Li, Y., Wang, J., Li, Q., & Xiong, W. (2026). ASIV Attenuates Cisplatin‐Induced Proximal Tubular Injury by Enhancing Mitochondrial Biogenesis and Mitophagy Through the ADRA1A / AMPK / FOXO3A Pathway. The FASEB Journal, 40(17). https://doi.org/10.1096/fj.202602118r

Vancouver

Wang M, Peng W, Wei Y, Yu H, Luo Y, Zhang Q, et al. ASIV Attenuates Cisplatin‐Induced Proximal Tubular Injury by Enhancing Mitochondrial Biogenesis and Mitophagy Through the ADRA1A / AMPK / FOXO3A Pathway. The FASEB Journal. 2026;40(17). doi:10.1096/fj.202602118r

BibTeX
@article{Wang2026,
  author = {Wang, Meng and Peng, Wang and Wei, Yani and Yu, Hangxing and Luo, Yan and Zhang, Qin and Guan, Xu and Li, Ying and Wang, Jianwei and Li, Qiurui and Xiong, Weijian},
  title = {ASIV Attenuates Cisplatin‐Induced Proximal Tubular Injury by Enhancing Mitochondrial Biogenesis and Mitophagy Through the ADRA1A / AMPK / FOXO3A Pathway},
  journal = {The FASEB Journal},
  year = {2026},
  volume = {40},
  number = {17},
  doi = {10.1096/fj.202602118r}
}
Kostenlos starten →